About
Argentina-born, London-based software entrepreneur whose career moved from online financial services and strategy consulting into product-led company building. Blinder incorporated Tictrac in 2010, guided its shift from personal analytics to B2B digital health and wellness, raised institutional capital and sold it to Dialogue in 2022. He left Tictrac's board in 2023 and now leads Symbe, an AI-assisted business-case platform derived from lessons learned selling Tictrac to enterprises.
Beyond investing
- Awards
- Tictrac won Best New Company at Health 2.0 in San Francisco in 2012. Contemporary coverage also placed the company among 15 digital-health influencers; the recognition applied to Tictrac and its market presence, not a separately adjudicated personal award.
- More
- UK filings identify him as Luis Martin Blinder Acenal, born November 1975. He used Spanish nationality and UK residence at Tictrac and British nationality and English residence at Symbe; company and media sources style him Martin or Martín Blinder. The Independent describes him as Argentina-born and says he worked across the consumer-web industry in Spain, the United States and elsewhere before founding Tictrac in London. Tictrac Limited was incorporated and Blinder appointed director and secretary on 7 October 2010. Later biographies often round the founding year to 2011, likely reflecting launch or operating chronology rather than legal formation. Tictrac began as a broad lifestyle-data dashboard, publicly launching in 2013 with integrations such as Fitbit and Runkeeper. After winning at Health 2.0 in 2012, Blinder narrowed the proposition toward health, then built enterprise and employee-wellbeing products. A July 2016 round brought $5.3 million. Puma later led a $7.5 million investment announced in 2020, saying cumulative capital reached $17 million and naming Andy Murray and Carmelo Anthony among existing company investors. By 2020–21 Tictrac said it worked with five of the 15 largest global insurers and thousands of employers, including relationships with Aviva, Allianz, Prudential and Generali. These are company or investor-reported distribution claims, not audited user outcomes. Dialogue completed the acquisition on 30 April 2022. The announced structure was C$24 million cash at closing plus up to C$32 million contingent on revenue milestones, for a maximum C$56 million; the maximum was not a guaranteed realized price. Dialogue reported a Tictrac loss in Q1 2023 while noting revenue and gross-margin contributions. CIBC analysis described slower international sales cycles, lower-than-expected Tictrac ARR and an earn-out threshold it considered unlikely to be met. No reviewed primary disclosure established the final contingent payout. Symbe announced a £1.2 million Concept Ventures-led pre-seed in 2024. A registry-based financing report estimates a further £3.7 million seed in 2026 from share-allotment filings; no reviewed company announcement disclosed the syndicate or exact cash proceeds, so that figure remains qualified. Symbe's official team page says he enjoys playing with his four-year-old son, home-barista practice and calisthenics. No reliable reviewed source established a spouse, broader family details or exact birth date.
From Luis's own website — common ground for a warm intro.
Co-founder at Symbe
Intro paths
In turn, Luis can intro founders to Symbe's investors below.
Symbe's investors · 5
Co-founders at Symbe
Experience
Investment themes
5 documented themes from Luis's essays, talks and portfolio, grouped by what they say about founders.
▶Health, frontier & community1
Consumer engagement before treatment2012
Blinder repeatedly argues that people need useful data, motivation and behavioral design to take more responsibility for health before clinical intervention is required.
For founders: Relevant to preventive-health founders balancing engagement claims with demonstrable outcomes.
▶More themes3
Data should produce action, not dashboards2021
His Tictrac work progressed from aggregating personal data toward contextual recommendations, campaigns and insurer/employer interventions intended to change behavior.
For founders: A useful product lesson for founders moving from instrumentation to decision support.
Business cases as collaborative decision tools2023
Symbe grew from Tictrac's 18-month first major sale: a customer champion asked for a quantified internal case, the teams built it together, won the account and retained it. Blinder now treats that artifact as the bond between buyer and seller.
For founders: Directly relevant to enterprise founders who must make value legible to champions, finance and economic buyers.
Turn operating friction into a product2024
Symbe converts a repetitive internal Tictrac sales process—Excel models, presentations and bespoke narratives—into a standardized AI-assisted workflow.
For founders: A positive repeat-founder pattern: productize a painful, repeatedly observed workflow with known buyers.
▶Governance & network states1
Whole-person employee wellbeing2022
He frames mental, physical, social and financial wellbeing as interconnected, criticizing fragmented tick-box programs and emphasizing personalization and engagement.
For founders: Relevant to workplace-benefits founders designing integrated products rather than isolated perks.
Podcasts & interviews
featuring Luis Martin Blinder AcenalSymbe raises £1.2m for business-case AI
UKTN · uktech.news
HRchat with Martin Blinder: Four Pillars of Employee Wellness
HR Gazette / HRchat · hr-gazette.com
#170: The Story of Tictrac with Martîn Blinder
The Healthtech Podcast · podcasts.apple.com
Interview with Martin Blinder, Founder and CEO of Tictrac
TechRound · techround.co.uk
The future of health technology
Building Better Healthcare · buildingbetterhealthcare.com
Tictrac: the startup that wants to help solve the self care crisis
The Independent · the-independent.com
2 more appearances
Writing
Bylined article arguing that wearable data should help insurers move from transactional payers to preventive-health partners.
One of three archived presentation decks under Blinder's profile; authorship is platform-attributed.
Bylined argument for health-engagement platforms and healthier work patterns in Asia.
Bylined article on social connection as part of integrated employee wellbeing.
Bylined workplace-wellbeing article connecting knowledge to sustained employee action.
Frequently asked questions
- Who is Martin Blinder of Tictrac?
- He is Luis Martin Blinder Acenal, born in November 1975, an Argentina-born London technology founder publicly known as Martin or Martín Blinder. Companies House links him continuously from Tictrac's 2010 incorporation to Symbe's 2023 incorporation.
- Is he the psychiatrist Martin Blinder?
- No. The Tictrac founder is a 1975-born technology entrepreneur whose legal surname is Blinder Acenal. The similarly named US forensic psychiatrist is a different, much older person with a medical career.
- When did Martin Blinder found Tictrac?
- The strongest primary date is 7 October 2010, when Tictrac Limited was incorporated and he became director and secretary. Some later biographies use 2011, likely reflecting launch or operating milestones.
- What did Tictrac do?
- It began as a personal data and lifestyle dashboard, then focused on health engagement. Its later B2B SaaS products gave insurers and employers personalized content, campaigns, challenges and behavioral insights intended to support healthier choices.
- What happened to Tictrac?
- Dialogue Health Technologies completed its purchase on 30 April 2022. The headline maximum was C$56 million, but only C$24 million was due at closing; up to C$32 million depended on revenue milestones, and the reviewed record does not establish the final earn-out.
- Did Martin Blinder remain after Tictrac's acquisition?
- Yes initially: Dialogue said he would continue leading Tictrac and report to CEO Cherif Habib. His Companies House directorship and secretary appointments ended on 1 September 2023.
- What is Martin Blinder doing now?
- He is cofounder, CEO and a director of Symbe, an AI-powered collaborative business-case platform incorporated in October 2023.
- Why did he start Symbe?
- At Tictrac, a major enterprise deal took more than 18 months until a customer champion asked for help proving value internally. The jointly built business case won the deal and became a repeatable sales practice; Symbe productizes that workflow.
- Is Martin Blinder an angel investor?
- No reviewed primary or reputable claim-level source documents a personal startup investment. Tictrac's and Symbe's investors are company backers and should not be assigned to his personal portfolio.
- What is publicly known about his education and personal life?
- An aggregated professional profile reports a BA in Economics from Trinity College and attendance at United Nations International School; no primary school record was found. Symbe's official page says he has a young son and enjoys coffee-making and calisthenics. Broader household details remain private.
- Who is Luis Martin Blinder Acenal?
- Argentina-born, London-based software entrepreneur whose career moved from online financial services and strategy consulting into product-led company building. Blinder incorporated Tictrac in 2010, guided its shift from personal analytics to B2B digital health and wellness, raised institutional capital and sold it to Dialogue in 2022. He left Tictrac's board in 2023 and now leads Symbe, an AI-assisted business-case platform derived from lessons learned selling Tictrac to enterprises.
- Where does Luis Martin Blinder Acenal work?
- Luis Martin Blinder Acenal is Co-founder of Symbe.
- What companies did Luis Martin Blinder Acenal found?
- Luis Martin Blinder Acenal founded Symbe.
- Where did Luis Martin Blinder Acenal go to school?
- Luis Martin Blinder Acenal studied at Trinity College, Hartford (BA, Economics); United Nations International School.